Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

tezacaftor-ivacaftor

tezacaftor-ivacaftor
  • Non-formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Symdeko TABLET, ORAL 100 mg-150 mg      
Comments:

Symdeko is supplied as a co-packaged tezacaftor 100 mg-ivacaftor 150 mg combination tablet with an additional 150 mg ivacaftor tablet. Symdeko is non-formulary, not stocked. Inpatient may use own supply. Defer initiation to after dischage.

Reviewed: 26 June 18 (Symdeko)

Last updated: Jun. 28, 2018






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved